25 trends tracked about this subject — the full history, oldest to newest below.
A new 'game-changing' saliva-based test aims to drastically reduce the years-long diagnostic wait for endometriosis, a condition affecting 190 million women.
Patients are facing restricted access to GLP-1 drugs like Ozempic and Wegovy due to high costs and restrictive insurance policies.
Fidelity's 25th annual estimate warns 2026 retirees may face healthcare costs totaling $185,500, challenging assumptions about Medicare coverage.
CVS Pharmacy rolls out a nationwide service to fill pet prescriptions across its thousands of locations.
Rising inflation and healthcare costs are forcing millions of Americans to delay medical care or struggle to afford assisted living.
The FDA has approved a first-of-its-kind daily oral pill from Merck designed to slash cholesterol levels.
A new Israeli ultrasound procedure and advanced technologies offer fresh hope for patients suffering from enlarged prostates.
A new generation of Alzheimer's treatments, including Roche's brainshuttle therapy, may stop the disease before symptoms even appear.
As Neuralink uses invasive skull surgery, China's BrainCo and rival firms bet on wearable brain-computer interfaces for the mass market.
New medical tests could transform endometriosis diagnosis from years of waiting to days, drawing widespread attention from health groups.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Trump’s student‑loan caps are prompting future doctors to rethink their path
Peptide therapy has emerged as a major wellness trend, sparking concerns over the safety and regulatory status of products in a rapidly growing market.
The National Institutes of Health has officially launched the 'All of Us' research program, now recognized as the world's largest integrated health database.
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.
Nasdaq shows signs of recovery while Comcast gains following the announcement of a planned corporate split.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Major pharmacy retailers are expanding support services as a new Medicare program launches to reduce costs for GLP-1 weight management medications.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
An AI model successfully diagnosed rare diseases in 18 children after doctors were stumped.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent reports indicate that testosterone therapy is frequently being prescribed to men without following established clinical guidelines.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
US employers may halt GLP-1 drug coverage in 2027 amid rising costs and usage spikes